ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF
US Application 18/035,427
Filed on 2023-05-04
Filed on 2023-05-04
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
China
202310701331.7
Filed on 2023-06-13
202310701331.7
Filed on 2023-06-13
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Patent Cooperation Treaty
PCT/US2023/069461
Filed on 2023-06-30
PCT/US2023/069461
Filed on 2023-06-30
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION
European Patent
23185846.5
Filed on 2023-07-17
23185846.5
Filed on 2023-07-17
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Hong Kong
62023074794.6
Filed on 2023-06-21
62023074794.6
Filed on 2023-06-21
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
Japan
2023-091878
Filed on 2023-06-02
2023-091878
Filed on 2023-06-02
ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS
US Application 18/323,493
Filed on 2023-05-25
Filed on 2023-05-25
Anti-Viral Compositions And Methods Of Making And Using
US Application 17/641,264
Filed on 2022-03-08
Filed on 2022-03-08
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
European Patent
20774960.7
Filed on 2020-09-17
20774960.7
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US Application 17/753,706
Filed on 2020-09-17
Filed on 2020-09-17